Differential virulence and pathogenesis of West Nile viruses

Viruses

Volumn 5, Issue 11, 2013, Pages 2856-2880

  Donadieu, Emilie ^a   Bahuon, Céline ^a   Lowenski, Steeve ^a   Zientara, Stéphan ^a   Coulpier, Muriel ^a   Lecollinet, Sylvie ^a  

^a INRA   (France)

Author keywords

Central nervous system; Immunity; Inflammation; Neuronal injury; Pathogenesis; Virulence; West Nile virus strains

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTRUCTURAL PROTEIN 2; RANTES; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

ANTIGENICITY; ARTICLE; BLOOD BRAIN BARRIER; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPIDEMIC; GENETIC LINE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; VIRAL CLEARANCE; VIRAL GENETICS; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84888144998     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5112856     Document Type: Article

References (166)

1. Kramer, L.D.;Li, J.;Shi, P.Y. West Nile virus. Lancet Neurol. 2007, 6, 171-181.
2. Smithburn, K.C.;Hughes, T.P.;Burke, A.W.;Paul, J.H. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 1940, 20, 471-492.
3. Hayes, E.B.;Komar, N.;Nasci, R.S.;Montgomery, S.P.;O'Leary, D.R.;Campbell, G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 2005, 11, 1167-1173.
4. Hayes, E.B.;Gubler, D.J. West Nile virus: Epidemiology and clinical features of an emerging epidemic in the United States. Ann. Rev. Med. 2006, 57, 181-194.
5. Leis, A.A.;Fratkin, J.;Stokic, D.S.;Harrington, T.;Webb, R.M.;Slavinski, S.A. West Nile poliomyelitis. Lancet Infect. Dis. 2003, 3, 9-10.
6. Petersen, L.R.;Marfin, A.A. West Nile virus: A primer for the clinician. Ann. Intern. Med. 2002, 137, 173-179.
7. Cao, N.J.;Ranganathan, C.;Kupsky, W.J.;Li, J. Recovery and prognosticators of paralysis in West Nile virus infection. J. Neurol. Sci. 2005, 236, 73-80.
8. Sejvar, J.J.;Haddad, M.B.;Tierney, B.C.;Campbell, G.L.;Marfin, A.A.;van Gerpen, J.A.;Fleischauer, A.;Leis, A.A.;Stokic, D.S.;Petersen, L.R. Neurologic manifestations and outcome of West Nile virus infection. J. Am. Med. Assoc. 2003, 290, 511-515.
9. Klee, A.L.;Maidin, B.;Edwin, B.;Poshni, I.;Mostashari, F.;Fine, A.;Layton, M.;Nash, D. Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis. 2004, 10, 1405-1411.
10. Sejvar, J.J.;Bode, A.V.;Marfin, A.A.;Campbell, G.L.;Pape, J.;Biggerstaff, B.J.;Petersen, L.R. West Nile Virus-associated flaccid paralysis outcome. Emerg. Infect. Dis. 2006, 12, 514-516.
11. Sejvar, J.J. The long-term outcomes of human West Nile virus infection. Clin. Infect. Dis. 2007, 44, 1617-1624.
12. De Filette, M.;Ulbert, S.;Diamond, M.;Sanders, N.N. Recent progress in West Nile virus diagnosis and vaccination. Vet. Res. 2012, 43, doi:10.1186/1297-9716-43-16.
13. Zeller, H.G.;Schuffenecker, I. West Nile virus: An overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur. J. Clin. Microbiol. Infect. Dis. 2004, 23, 147-156.
14. Calistri, P.;Giovannini, A.;Hubalek, Z.;Ionescu, A.;Monaco, F.;Savini, G.;Lelli, R. Epidemiology of west nile in europe and in the mediterranean basin. Open Virol. J. 2010, 4, 29-37.
15. Bin, H.;Grossman, Z.;Pokamunski, S.;Malkinson, M.;Weiss, L.;Duvdevani, P.;Banet, C.;Weisman, Y.;Annis, E.;Gandaku, D.;et al. West Nile fever in Israel 1999-2000: From geese to humans. Ann. NY Acad. Sci. 2001, 951, 127-142.
16. Kopel, E.;Amitai, Z.;Bin, H.;Shulman, L.M.;Mendelson, E.;Sheffer, R. Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010. Available online: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19894 (accessed at 19 August 2013).
17. Bakonyi, T.;Ferenczi, E.;Erdelyi, K.;Kutasi, O.;Csorgo, T.;Seidel, B.;Weissenbock, H.;Brugger, K.;Ban, E.;Nowotny, N. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. Vet. Microbiol. 2013, 165, 61-70.
18. Pradier, S.;Lecollinet, S.;Leblond, A. West Nile virus epidemiology and factors triggering change in its distribution in Europe. Rev. Sci. Tech. 2012, 31, 829-844.
19. Sirbu, A.;Ceianu, C.S.;Panculescu-Gatej, R.I.;Vazquez, A.;Tenorio, A.;Rebreanu, R.;Niedrig, M.;Nicolescu, G.;Pistol, A. Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19762 (accessed at 14 August 2013).
20. Danis, K.;Papa, A.;Theocharopoulos, G.;Dougas, G.;Athanasiou, M.;Detsis, M.;Baka, A.;Lytras, T.;Mellou, K.;Bonovas, S.;et al. Outbreak of West Nile virus infection in Greece, 2010. Emerg. Infect. Dis. 2011, 17, 1868-1872.
21. Platonov, A.E.;Karan, L.S.;Shopenskaia, T.A.;Fedorova, M.V.;Koliasnikova, N.M.;Rusakova, N.M.;Shishkina, L.V.;Arshba, T.E.;Zhuravlev, V.I.;Govorukhina, M.V.;et al. Genotyping of West Nile fever virus strains circulating in southern Russia as an epidemiological investigation method: Principles and results. Zh. Mikrobiol. Epidemiol. immunobiol. 2011, 2011, 29-37.
22. Frost, M.J.;Zhang, J.;Edmonds, J.H.;Prow, N.A.;Gu, X.;Davis, R.;Hornitzky, C.;Arzey, K.E.;Finlaison, D.;Hick, P.;et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 2012, 18, 792-800.
23. Venter, M.;Human, S.;Zaayman, D.;Gerdes, G.H.;Williams, J.;Steyl, J.;Leman, P.A.;Paweska, J.T.;Setzkorn, H.;Rous, G.;et al. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg. Infect. Dis. 2009, 15, 877-884.
24. Venter, M.;Swanepoel, R. West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis. 2010, 10, 659-664.
25. Tamura, K.;Peterson, D.;Peterson, N.;Stecher, G.;Nei, M.;Kumar, S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28, 2731-2739.
26. Ciccozzi, M.;Peletto, S.;Cella, E.;Giovanetti, M.;Lai, A.;Gabanelli, E.;Acutis, P.L.;Modesto, P.;Rezza, G.;Platonov, A.E.;et al. Epidemiological history and phylogeography of West Nile virus lineage 2. Infect. Genet. Evol. 2013, 17, 46-50.
27. Blitvich, B.J. Transmission dynamics and changing epidemiology of West Nile virus. Anim. Health Res. Rev. 2008, 9, 71-86.
28. LaDeau, S.L.;Kilpatrick, A.M.;Marra, P.P. West Nile virus emergence and large-scale declines of North American bird populations. Nature 2007, 447, 710-713.
29. Chung, W.M.;Buseman, C.M.;Joyner, S.N.;Hughes, S.M.;Fomby, T.B.;Luby, J.P.;Haley, R.W. The 2012 West Nile encephalitis epidemic in Dallas, Texas. J. Am. Med. Assoc. 2013, 310, 297-307.
30. Duggal, N.K.;D'Anton, M.;Xiang, J.;Seiferth, R.;Day, J.;Nasci, R.;Brault, A.C. Sequence analyses of 2012 west nile virus isolates from Texas fail to associate viral genetic factors with outbreak magnitude. Am. J. Trop. Medi. Hyg. 2013, 89, 205-210.
31. Cho, H.;Diamond, M.S. Immune responses to West Nile virus infection in the central nervous system. Viruses 2012, 4, 3812-3830.
32. Lim, S.M.;Koraka, P.;Osterhaus, A.D.;Martina, B.E. West Nile virus: Immunity and pathogenesis. Viruses 2011, 3, 811-828.
33. Suthar, M.S.;Diamond, M.S.;Gale, M., Jr. West Nile virus infection and immunity. Nat. Rev. Microbiol. 2013, 11, 115-128.
34. Samuel, M.A.;Diamond, M.S. Pathogenesis of West Nile Virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 2006, 80, 9349-9360.
35. Diamond, M.S.;Gale, M., Jr. Cell-intrinsic innate immune control of West Nile virus infection. Trends. Immunol. 2012, 33, 522-530.
36. Ulbert, S. West Nile virus: The complex biology of an emerging pathogen. Intervirology 2011, 54, 171-184.
37. Guarner, J.;Shieh, W.J.;Hunter, S.;Paddock, C.D.;Morken, T.;Campbell, G.L.;Marfin, A.A.;Zaki, S.R. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum. Pathol. 2004, 35, 983-990.
38. Kleinschmidt-DeMasters, B.K.;Marder, B.A.;Levi, M.E.;Laird, S.P.;McNutt, J.T.;Escott, E.J.;Everson, G.T.;Tyler, K.L. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: Clinical, laboratory, diagnostic, and neuropathological features. Arch. Neurol. 2004, 61, 1210-1220.
39. Samuel, M.A.;Morrey, J.D.;Diamond, M.S. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J. Virol. 2007, 81, 2614-2623.
40. Bondre, V.P.;Jadi, R.S.;Mishra, A.C.;Yergolkar, P.N.;Arankalle, V.A. West Nile virus isolates from India: Evidence for a distinct genetic lineage. J. Gen. Virol. 2007, 88, 875-884.
41. Erdelyi, K.;Ursu, K.;Ferenczi, E.;Szeredi, L.;Ratz, F.;Skare, J.;Bakonyi, T. Clinical and pathologic features of lineage 2 West Nile virus infections in birds of prey in Hungary. Vector Borne Zoonotic Dis. 2007, 7, 181-188.
42. Kutasi, O.;Bakonyi, T.;Lecollinet, S.;Biksi, I.;Ferenczi, E.;Bahuon, C.;Sardi, S.;Zientara, S.;Szenci, O. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. J. Vet. Intern. Med. 2011, 25, 586-591.
43. Magurano, F.;Remoli, M.E.;Baggieri, M.;Fortuna, C.;Marchi, A.;Fiorentini, C.;Bucci, P.;Benedetti, E.;Ciufolini, M.G.;Rizzo, C.;et al. Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin. Microbiol. Infect. 2012, 18, E545-E547.
44. Bakonyi, T.;Hubalek, Z.;Rudolf, I.;Nowotny, N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg. Infect. Dis. 2005, 11, 225-231.
45. Lvov, D.K.;Butenko, A.M.;Gromashevsky, V.L.;Kovtunov, A.I.;Prilipov, A.G.;Kinney, R.;Aristova, V.A.;Dzharkenov, A.F.;Samokhvalov, E.I.;Savage, H.M.;et al. West Nile virus and other zoonotic viruses in Russia: Examples of emerging-reemerging situations. Arch. Virol. Suppl. 2004, 18, 85-96.
46. Scherret, J.H.;Poidinger, M.;Mackenzie, J.S.;Broom, A.K.;Deubel, V.;Lipkin, W.I.;Briese, T.;Gould, E.A.;Hall, R.A. The relationships between West Nile and Kunjin viruses. Emerg. Infect. Dis. 2001, 7, 697-705.
47. Vazquez, A.;Sanchez-Seco, M.P.;Ruiz, S.;Molero, F.;Hernandez, L.;Moreno, J.;Magallanes, A.;Tejedor, C.G.;Tenorio, A. Putative new lineage of west nile virus, Spain. Emerg. Infect. Dis. 2010, 16, 549-552.
48. Traore-Lamizana, M.;Fontenille, D.;Diallo, M.;Ba, Y.;Zeller, H.G.;Mondo, M.;Adam, F.;Thonon, J.;Maiga, A. Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus. J. Med. Entomol. 2001, 38, 480-492.
49. May, F.J.;Davis, C.T.;Tesh, R.B.;Barrett, A.D. Phylogeography of West Nile virus: From the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J. Virol. 2011, 85, 2964-2974.
50. Monini, M.;Falcone, E.;Busani, L.;Romi, R.;Ruggeri, F.M. West nile virus: Characteristics of an african virus adapting to the third millennium world. Open Virol. J. 2010, 4, 42-51.
51. Rappole, J.H.;Compton, B.W.;Leimgruber, P.;Robertson, J.;King, D.I.;Renner, S.C. Modeling movement of West Nile virus in the Western hemisphere. Vector Borne Zoonotic Dis. 2006, 6, 128-139.
52. Rappole, J.H.;Derrickson, S.R.;Hubalek, Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg. Infect. Dis. 2000, 6, 319-328.
53. Zehender, G.;Ebranati, E.;Bernini, F.;Lo Presti, A.;Rezza, G.;Delogu, M.;Galli, M.;Ciccozzi, M. Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect. Genet. Evol. 2011, 11, 646-653.
54. Besselaar, T.G.;Blackburn, N.K. Antigenic analysis of West Nile virus strains using monoclonal antibodies. Arch. Virol. 1988, 99, 75-88.
55. Morvan, J.;Besselaar, T.;Fontenille, D.;Coulanges, P. Antigenic variations in West Nile virus strains isolated in Madagascar since 1978. Res. Virol. 1990, 141, 667-676.
56. Beasley, D.W.;Barrett, A.D. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 2002, 76, 13097-13100.
57. Beasley, D.W.;Li, L.;Suderman, M.T.;Barrett, A.D. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296, 17-23.
58. Brault, A.C.;Langevin, S.A.;Bowen, R.A.;Panella, N.A.;Biggerstaff, B.J.;Miller, B.R.;Komar, N. Differential virulence of West Nile strains for American crows. Emerg. Infect. Dis. 2004, 10, 2161-2168.
59. Langevin, S.A.;Brault, A.C.;Panella, N.A.;Bowen, R.A.;Komar, N. Variation in virulence of West Nile virus strains for house sparrows (Passer domesticus). Am. J. Trop. Med. Hyg. 2005, 72, 99-102.
60. Adams, S.C.;Broom, A.K.;Sammels, L.M.;Hartnett, A.C.;Howard, M.J.;Coelen, R.J.;Mackenzie, J.S.;Hall, R.A. Glycosylation and antigenic variation among Kunjin virus isolates. Virology 1995, 206, 49-56.
61. Berthet, F.X.;Zeller, H.G.;Drouet, M.T.;Rauzier, J.;Digoutte, J.P.;Deubel, V. Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J. Gen. Virol 1997, 78, 2293-2297.
62. Chambers, T.J.;Halevy, M.;Nestorowicz, A.;Rice, C.M.;Lustig, S. West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J. Gen. Virol. 1998, 79, 2375-2380.
63. Beasley, D.W.;Whiteman, M.C.;Zhang, S.;Huang, C.Y.;Schneider, B.S.;Smith, D.R.;Gromowski, G.D.;Higgs, S.;Kinney, R.M.;Barrett, A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 2005, 79, 8339-8347.
64. Murata, R.;Eshita, Y.;Maeda, A.;Maeda, J.;Akita, S.;Tanaka, T.;Yoshii, K.;Kariwa, H.;Umemura, T.;Takashima, I. Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. Am. J. Trop. Med. Hyg. 2010, 82, 696-704.
65. Langevin, S.A.;Bowen, R.A.;Ramey, W.N.;Sanders, T.A.;Maharaj, P.D.;Fang, Y.;Cornelius, J.;Barker, C.M.;Reisen, W.K.;Beasley, D.W.;et al. Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J. Gen. Virol. 2011, 92, 2810-2820.
66. Moudy, R.M.;Zhang, B.;Shi, P.Y.;Kramer, L.D. West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology 2009, 387, 222-228.
67. Brault, A.C.;Huang, C.Y.;Langevin, S.A.;Kinney, R.M.;Bowen, R.A.;Ramey, W.N.;Panella, N.A.;Holmes, E.C.;Powers, A.M.;Miller, B.R. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat. Genet. 2007, 39, 1162-1166.
68. Audsley, M.;Edmonds, J.;Liu, W.;Mokhonov, V.;Mokhonova, E.;Melian, E.B.;Prow, N.;Hall, R.A.;Khromykh, A.A. Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology 2011, 414, 63-73.
69. Liu, W.J.;Wang, X.J.;Clark, D.C.;Lobigs, M.;Hall, R.A.;Khromykh, A.A. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 2006, 80, 2396-2404.
70. Botha, E.M.;Markotter, W.;Wolfaardt, M.;Paweska, J.T.;Swanepoel, R.;Palacios, G.;Nel, L.H.;Venter, M. Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg. Infect. Dis. 2008, 14, 222-230.
71. Borisevich, V.;Seregin, A.;Nistler, R.;Mutabazi, D.;Yamshchikov, V. Biological properties of chimeric West Nile viruses. Virology 2006, 349, 371-381.
72. Pogodina, V.V.;Frolova, M.P.;Malenko, G.V.;Fokina, G.I.;Koreshkova, G.V.;Kiseleva, L.L.;Bochkova, N.G.;Ralph, N.M. Study on West Nile virus persistence in monkeys. Arch. Virol. 1983, 75, 71-86.
73. Xiao, S.Y.;Guzman, H.;Zhang, H.;Travassos da Rosa, A.P.;Tesh, R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): A model for West Nile encephalitis. Emerg. Infect. Dis. 2001, 7, 714-721.
74. Bai, F.;Kong, K.F.;Dai, J.;Qian, F.;Zhang, L.;Brown, C.R.;Fikrig, E.;Montgomery, R.R. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J. Infect. Dis. 2010, 202, 1804-1812.
75. Lim, P.Y.;Behr, M.J.;Chadwick, C.M.;Shi, P.Y.;Bernard, K.A. Keratinocytes are cell targets of West Nile virus in vivo. J. Virol. 2011, 85, 5197-5201.
76. Welte, T.;Reagan, K.;Fang, H.;Machain-Williams, C.;Zheng, X.;Mendell, N.;Chang, G.J.;Wu, P.;Blair, C.D.;Wang, T. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J. Gen. Virol. 2009, 90, 2660-2668.
77. Byrne, S.N.;Halliday, G.M.;Johnston, L.J.;King, N.J. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J. Invest. Dermatol. 2001, 117, 702-709.
78. Johnston, L.J.;Halliday, G.M.;King, N.J. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Invest. Dermatol. 2000, 114, 560-568.
79. McCandless, E.E.;Zhang, B.;Diamond, M.S.;Klein, R.S. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. USA 2008, 105, 11270-11275.
80. Ramos, H.J.;Lanteri, M.C.;Blahnik, G.;Negash, A.;Suthar, M.S.;Brassil, M.M.;Sodhi, K.;Treuting, P.M.;Busch, M.P.;Norris, P.J.;et al. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012, 8, e1003039.
81. Wang, S.;Welte, T.;McGargill, M.;Town, T.;Thompson, J.;Anderson, J.F.;Flavell, R.A.;Fikrig, E.;Hedrick, S.M.;Wang, T. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J. Immunol. 2008, 181, 2084-2091.
82. Samuel, M.A.;Diamond, M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79, 13350-13361.
83. Anderson, J.F.;Rahal, J.J. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg. Infect. Dis. 2002, 8, 107-108.
84. Morrey, J.D.;Day, C.W.;Julander, J.G.;Blatt, L.M.;Smee, D.F.;Sidwell, R.W. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chem. Chemother. 2004, 15, 101-109.
85. Keller, B.C.;Fredericksen, B.L.;Samuel, M.A.;Mock, R.E.;Mason, P.W.;Diamond, M.S.;Gale, M., Jr. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 2006, 80, 9424-9434.
86. Liu, W.J.;Chen, H.B.;Wang, X.J.;Huang, H.;Khromykh, A.A. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J. Virol. 2004, 78, 12225-12235.
87. Munoz-Jordan, J.L.;Laurent-Rolle, M.;Ashour, J.;Martinez-Sobrido, L.;Ashok, M.;Lipkin, W.I.;Garcia-Sastre, A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 2005, 79, 8004-8013.
88. Evans, J.D.;Seeger, C. Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J. Virol. 2007, 81, 11809-11816.
89. Laurent-Rolle, M.;Boer, E.F.;Lubick, K.J.;Wolfinbarger, J.B.;Carmody, A.B.;Rockx, B.;Liu, W.;Ashour, J.;Shupert, W.L.;Holbrook, M.R.;et al. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J. Virol. 2010, 84, 3503-3515.
90. Daffis, S.;Lazear, H.M.;Liu, W.J.;Audsley, M.;Engle, M.;Khromykh, A.A.;Diamond, M.S. The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response. J. Virol. 2011, 85, 5664-5668.
91. Diamond, M.S.;Shrestha, B.;Marri, A.;Mahan, D.;Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 2003, 77, 2578-2586.
92. Vargin, V.V.;Semenov, B.F. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol. 1986, 30, 303-308.
93. Wang, T.;Scully, E.;Yin, Z.;Kim, J.H.;Wang, S.;Yan, J.;Mamula, M.;Anderson, J.F.;Craft, J.;Fikrig, E. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 2003, 171, 2524-2531.
94. Arjona, A.;Wang, P.;Montgomery, R.R.;Fikrig, E. Innate immune control of West Nile virus infection. Cell Microbiol. 2011, 13, 1648-1658.
95. Shrestha, B.;Wang, T.;Samuel, M.A.;Whitby, K.;Craft, J.;Fikrig, E.;Diamond, M.S. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 2006, 80, 5338-5348.
96. Shrestha, B.;Samuel, M.A.;Diamond, M.S. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 2006, 80, 119-129.
97. Fang, H.;Welte, T.;Zheng, X.;Chang, G.J.;Holbrook, M.R.;Soong, L.;Wang, T. Gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol. Med. Microbiol. 2010, 59, 71-80.
98. Kulkarni, A.B.;Mullbacher, A.;Blanden, R.V. Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol. Cell Biol. 1991, 69, 71-80.
99. Lin, Y.L.;Huang, Y.L.;Ma, S.H.;Yeh, C.T.;Chiou, S.Y.;Chen, L.K.;Liao, C.L. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 1997, 71, 5227-5235.
100. Saxena, S.K.;Singh, A.;Mathur, A. Antiviral effect of nitric oxide during Japanese encephalitis virus infection. Int. J. Exp. Pathol. 2000, 81, 165-172.
101. Ben-Nathan, D.;Huitinga, I.;Lustig, S.;van Rooijen, N.;Kobiler, D. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch. Virol. 1996, 141, 459-469.
102. Appler, K.K.;Brown, A.N.;Stewart, B.S.;Behr, M.J.;Demarest, V.L.;Wong, S.J.;Bernard, K.A. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 2010, 5, e10649.
103. Samuel, M.A.;Wang, H.;Siddharthan, V.;Morrey, J.D.;Diamond, M.S. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc. Natl. Acad. Sci. USA 2007, 104, 17140-17145.
104. Verma, S.;Lo, Y.;Chapagain, M.;Lum, S.;Kumar, M.;Gurjav, U.;Luo, H.;Nakatsuka, A.;Nerurkar, V.R. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology 2009, 385, 425-433.
105. Pardridge, W.M. Brain metabolism: A perspective from the blood-brain barrier. Physiol. Rev. 1983, 63, 1481-1535.
106. Muldoon, L.L.;Alvarez, J.I.;Begley, D.J.;Boado, R.J.;Del Zoppo, G.J.;Doolittle, N.D.;Engelhardt, B.;Hallenbeck, J.M.;Lonser, R.R.;Ohlfest, J.R.;et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J. Cereb. blood Flow Metab. 2013, 33, 13-21.
107. Ballabh, P.;Braun, A.;Nedergaard, M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16, 1-13.
108. Shen, J.;SS, T.T.;Schrieber, L.;King, N.J. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 1997, 71, 9323-9332.
109. King, N.J.;Shrestha, B.;Kesson, A.M. Immune modulation by flaviviruses. Adv. Virus Res. 2003, 60, 121-155.
110. Dai, J.;Wang, P.;Bai, F.;Town, T.;Fikrig, E. Icam-1 participates in the entry of west nile virus into the central nervous system. J. Virol. 2008, 82, 4164-4168.
111. Drevets, D.A.;Leenen, P.J. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect. 2000, 2, 1609-1618.
112. Greenwood, J.;Etienne-Manneville, S.;Adamson, P.;Couraud, P.O. Lymphocyte migration into the central nervous system: Implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol. 2002, 38, 315-322.
113. Hubbard, A.K.;Rothlein, R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic. Biol. Med. 2000, 28, 1379-1386.
114. Morrey, J.D.;Olsen, A.L.;Siddharthan, V.;Motter, N.E.;Wang, H.;Taro, B.S.;Chen, D.;Ruffner, D.;Hall, J.O. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J. Gen. Virol. 2008, 89, 467-473.
115. Daffis, S.;Samuel, M.A.;Suthar, M.S.;Gale, M., Jr.;Diamond, M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82, 10349-10358.
116. Wang, T.;Town, T.;Alexopoulou, L.;Anderson, J.F.;Fikrig, E.;Flavell, R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10, 1366-1373.
117. Wang, P.;Dai, J.;Bai, F.;Kong, K.F.;Wong, S.J.;Montgomery, R.R.;Madri, J.A.;Fikrig, E. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J. Virol. 2008, 82, 8978-8985.
118. De Vries, H.E.;Blom-Roosemalen, M.C.;van Oosten, M.;de Boer, A.G.;van Berkel, T.J.;Breimer, D.D.;Kuiper, J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996, 64, 37-43.
119. Arjona, A.;Foellmer, H.G.;Town, T.;Leng, L.;McDonald, C.;Wang, T.;Wong, S.J.;Montgomery, R.R.;Fikrig, E.;Bucala, R. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 2007, 117, 3059-3066.
120. Sultana, H.;Neelakanta, G.;Foellmer, H.G.;Montgomery, R.R.;Anderson, J.F.;Koski, R.A.;Medzhitov, R.M.;Fikrig, E. Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-beta1/Smad6 signaling. J. Immunol. 2012, 189, 3150-3158.
121. Wilson, J.R.;de Sessions, P.F.;Leon, M.A.;Scholle, F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 2008, 82, 8262-8271.
122. Kong, K.F.;Delroux, K.;Wang, X.;Qian, F.;Arjona, A.;Malawista, S.E.;Fikrig, E.;Montgomery, R.R. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 2008, 82, 7613-7623.
123. Venter, M.;Myers, T.G.;Wilson, M.A.;Kindt, T.J.;Paweska, J.T.;Burt, F.J.;Leman, P.A.;Swanepoel, R. Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 2005, 342, 119-140.
124. Chambers, T.J.;Diamond, M.S. Pathogenesis of flavivirus encephalitis. Adv. Virus Res. 2003, 60, 273-342.
125. Hunsperger, E.A.;Roehrig, J.T. Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice. J. Neurovirol. 2006, 12, 129-139.
126. Morrey, J.D.;Siddharthan, V.;Wang, H.;Hall, J.O.;Skirpstunas, R.T.;Olsen, A.L.;Nordstrom, J.L.;Koenig, S.;Johnson, S.;Diamond, M.S. West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. J. Neurovirol. 2008, 14, 152-163.
127. Donadieu, E.;Lowenski, S.;Severly, J.-L.;Laloy, E.;Lilin, T.;Nowotny, N.;Richardson, J.;Zientara, S.;Lecollinet, S.;Coulpier, M. Comparison of the neuropathogenesis induced by two West Nile virus strains of lineage 1. PLoS One, submitted for publication.
128. Lucas, M.;Frenkiel, M.P.;Mashimo, T.;Guenet, J.L.;Deubel, V.;Despres, P.;Ceccaldi, P.E. The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the old world. Virol. J. 2004, 1, doi:10.1186/1743-422X-1-9.
129. Wang, Y.;Lobigs, M.;Lee, E.;Mullbacher, A. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 2003, 77, 13323-13334.
130. Lim, P.Y.;Louie, K.L.;Styer, L.M.;Shi, P.Y.;Bernard, K.A. Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology 2010, 400, 93-103.
131. Eldadah, A.H.;Nathanson, N. Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am. J. Epidemiol. 1967, 86, 776-790.
132. Cheeran, M.C.;Hu, S.;Sheng, W.S.;Rashid, A.;Peterson, P.K.;Lokensgard, J.R. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 2005, 11, 512-524.
133. Shrestha, B.;Gottlieb, D.;Diamond, M.S. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 2003, 77, 13203-13213.
134. Sitati, E.;McCandless, E.E.;Klein, R.S.;Diamond, M.S. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J. Virol. 2007, 81, 9801-9811.
135. Kelley, T.W.;Prayson, R.A.;Ruiz, A.I.;Isada, C.M.;Gordon, S.M. The neuropathology of West Nile virus meningoencephalitis-A report of two cases and review of the literature. Am. J. Clin. Pathol. 2003, 119, 749-753.
136. Parquet, M.C.;Kumatori, A.;Hasebe, F.;Morita, K.;Igarashi, A. West Nile virus-induced bax-dependent apoptosis. FEBS Lett. 2001, 500, 17-24.
137. Medigeshi, G.R.;Lancaster, A.M.;Hirsch, A.J.;Briese, T.;Lipkin, W.I.;Defilippis, V.;Fruh, K.;Mason, P.W.;Nikolich-Zugich, J.;Nelson, J.A. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J. Virol. 2007, 81, 10849-10860.
138. Ramanathan, M.P.;Chambers, J.A.;Pankhong, P.;Chattergoon, M.;Attatippaholkun, W.;Dang, K.;Shah, N.;Weiner, D.B. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 2006, 345, 56-72.
139. Yang, J.S.;Ramanathan, M.P.;Muthumani, K.;Choo, A.Y.;Jin, S.H.;Yu, Q.C.;Hwang, D.S.;Choo, D.K.;Lee, M.D.;Dang, K.;et al. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg. Infect. Dis. 2002, 8, 1379-1384.
140. Shieh, W.J.;Guarner, J.;Layton, M.;Fine, A.;Miller, J.;Nash, D.;Campbell, G.L.;Roehrig, J.T.;Gubler, D.J.;Zaki, S.R. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg. Infect. Dis. 2000, 6, 370-372.
141. Chu, J.J.;Ng, M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 2003, 84, 3305-3314.
142. Kumar, M.;Verma, S.;Nerurkar, V.R. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J. Neuroinflammation 2010, 7, doi:10.1186/1742-2094-7-73.
143. Benarroch, E.E. Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80, 1326-1338.
144. Liu, Y.;King, N.;Kesson, A.;Blanden, R.V.;Mullbacher, A. West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro. Ann. NY Acad. Sci. 1988, 540, 483-485.
145. Bradl, M.;Hohlfeld, R. Molecular pathogenesis of neuroinflammation. J. Neurol. Neurosurg. Psychiatry 2003, 74, 1364-1370.
146. Farina, C.;Aloisi, F.;Meinl, E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28, 138-145.
147. Giulian, D.;Li, J.;Leara, B.;Keenen, C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 1994, 25, 227-233.
148. Chen, C.J.;Ou, Y.C.;Lin, S.Y.;Raung, S.L.;Liao, S.L.;Lai, C.Y.;Chen, S.Y.;Chen, J.H. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J. Gen. Virol. 2010, 91, 1028-1037.
149. Ghoshal, A.;Das, S.;Ghosh, S.;Mishra, M.K.;Sharma, V.;Koli, P.;Sen, E.;Basu, A. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 2007, 55, 483-496.
150. Teeling, J.L.;Perry, V.H. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 2009, 158, 1062-1073.
151. Hussmann, K.L.;Samuel, M.A.;Kim, K.S.;Diamond, M.S.;Fredericksen, B.L. Differential replication of pathogenic and nonpathogenic strains of West Nile virus within astrocytes. J. Virol. 2013, 87, 2814-2822.
152. Shueb, R.H.;Papadimitriou, J.;Urosevic, N. Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice. Virus Res. 2011, 155, 455-461.
153. Morrey, J.D.;Siddharthan, V.;Wang, H.;Hall, J.O. Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus. PLoS One 2012, 7, e38672.
154. Tesh, R.B.;Siirin, M.;Guzman, H.;Travassos da Rosa, A.P.;Wu, X.;Duan, T.;Lei, H.;Nunes, M.R.;Xiao, S.Y. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J. Infect. Dis. 2005, 192, 287-295.
155. Murray, K.;Walker, C.;Herrington, E.;Lewis, J.A.;McCormick, J.;Beasley, D.W.;Tesh, R.B.;Fisher-Hoch, S. Persistent infection with West Nile virus years after initial infection. J. Infect. Dis. 2010, 201, 2-4.
156. Durrant, D.M.;Robinette, M.L.;Klein, R.S. IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J. Exp. Med. 2013, 210, 503-516.
157. Lazear, H.M.;Pinto, A.K.;Vogt, M.R.;Gale, M., Jr.;Diamond, M.S. Beta interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 2011, 85, 7186-7194.
158. Szretter, K.J.;Daffis, S.;Patel, J.;Suthar, M.S.;Klein, R.S.;Gale, M., Jr.;Diamond, M.S. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 2010, 84, 12125-12138.
159. Shrestha, B.;Diamond, M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 2004, 78, 8312-8321.
160. Glass, W.G.;Lim, J.K.;Cholera, R.;Pletnev, A.G.;Gao, J.L.;Murphy, P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202, 1087-1098.
161. Glass, W.G.;McDermott, D.H.;Lim, J.K.;Lekhong, S.;Yu, S.F.;Frank, W.A.;Pape, J.;Cheshier, R.C.;Murphy, P.M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 2006, 203, 35-40.
162. Klein, R.S.;Lin, E.;Zhang, B.;Luster, A.D.;Tollett, J.;Samuel, M.A.;Engle, M.;Diamond, M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79, 11457-11466.
163. Lim, J.K.;McDermott, D.H.;Lisco, A.;Foster, G.A.;Krysztof, D.;Follmann, D.;Stramer, S.L.;Murphy, P.M. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J. Infect. Dis. 2010, 201, 178-185.
164. Brien, J.D.;Uhrlaub, J.L.;Nikolich-Zugich, J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 2008, 181, 8568-8575.
165. Sitati, E.M.;Diamond, M.S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 2006, 80, 12060-12069.
166. Lanteri, M.C.;O'Brien, K.M.;Purtha, W.E.;Cameron, M.J.;Lund, J.M.;Owen, R.E.;Heitman, J.W.;Custer, B.;Hirschkorn, D.F.;Tobler, L.H.;et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 2009, 119, 3266-3277.